GME Meeting Planner
*Due to COVID-19, GME is holding this event as a live virtual webcast. All currently registered attendees will be notified via email. We will be welcoming additional registrations, as well. Please email us at [email protected] if you have any questions.
Join fellow healthcare professionals and learn from the world’s leading experts at this FREE comprehensive two-day conference, which will explore state of the art diagnostic and therapeutic issues in patients with mood disorders.
Access the program here: www.engagez.net/mood-disorder-2020
Please note, the site will not be live until the start time of the program. Materials will be avaialble for download once the site is live, but are not available in advance.
Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.
This activity is supported by independent educational grants from Neurocrine Biosciences and Sunovion.
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists and psychologists engaged in the care of patients with mood disorders.
After completing this activity, the participant should be better able to:
- Identify the mental health consequences of COVID-19
- Describe role of measurement-based care in mood disorders
- Utilize digital tools to diagnose and manage mood disorders
- Employ evidence based treatments for bipolar depression including treatment resistant patients
- Describe new molecular targets for treating depression
- Describe role of psychedelics in mood disorders
- Utilize telehealth when appropriate in mood disorder patients
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 11 contact hours (1.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number –JA4008162-9999-20-2305-L01-P
Type of Activity: Knowledge
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 11 contact hours. Designated for 2.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 11 contact hours.
AAPA Credit Designation Statement
This activity is designated for 11 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Psychologist Education
Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility of the program.
This program offers 11.0 continuing education credits for psychologists.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
*Tentative - please note, times may shift
*All times listed are ET
Day 1 - Friday, November 20, 2020
9:45 – 10:00 AM: Opening Remarks by Chair Prakash Masand MD (Duke-NUS)
10:00 – 11:00 AM: Keynote Address - "Novel Molecular Targets in the Treatment of MDD" Maurizio Fava, MD (Harvard)
11:00 – 12:00 PM: “COVID-19 and Mental Health Consequences” Craig Katz, MD (Mt. Sinai NY)
12:00 – 1:00 PM: Non-CME Educational Talk (Sunovion)
1:00 – 1:15 PM: Break
1:15 – 2:15 PM: “Psychedelics in Psychiatry: The New Frontier” Allan Young, MD (Institute of Psychiatry)
2:15 – 3:15 PM: Non-CME Educational Talk (Neurocrine Biosciences)
3:15 – 4:15 PM: “Digital Apps for Mood Disorder Patients: Standalone or Adjunct?” Diego Hidalgo-Mazzei, MD, PhD. (Univ of Barcelona)
4:15 – 4:30 PM: Break
4:30 – 5:30 PM: “Can We Integrate Measurement-Based Care into Psychiatric Practice?” Sanjay Mathew, MD (Baylor College of Medicine)
5:30 – 6:30 PM: “Irritability/Anger Attacks in Major Depression” Manish Jha, MD (NYU)
Day 2 - Saturday, November 21, 2020
9:45 – 10:00 AM: Opening Remarks by Chair
10:00 – 11:00 AM: “The Network Model of Symptoms in Mood Disorders” Joe Goldberg, MD (Mt Sinai NY)
11:00 – 12:00 PM: “Personalized Medicine for Mood Disorders: The Right Treatment for the Right Patient” Eduard Vieta, MD (Univ of Barcelona)
12:00 – 1:00 PM: Non-CME Educational Talk (Janssen)
1:00 – 1:15 PM: Break
1:15 – 2:15 PM: “Bipolar Depression: Can We Do Better?” Greg Mattingly, MD (Washington Univ)
2:15 – 3:15 PM: Non-CME Educational Talk (Allergan)
3:15 – 4:15 PM: “Tardive Dyskinesia and Affective Disorders: The Nuances in the 21st Century” Sanjay Gupta, MD (SUNY Buffalo)
4:15 – 4:30 PM: Break
4:30 - 5:30 PM: Non-CME Educational Talk (Acadia)
5:30 – 6:30 PM “Telehealth and Psychiatry in an Era of COVID-19” Peter Forster, MD (UCSF)